# Reply to Külls et al., “Residual confounding and outcome definition in observational comparisons of PDR-Acinetobacter baumannii therapies”

**Authors:** Konstantinos Pontikis, Ilias Karaiskos, Helen Giamarellou, George L. Daikos

PMC · DOI: 10.1128/aac.00104-26 · Antimicrobial Agents and Chemotherapy · 2026-03-16

## Full-text entities

- **Diseases:** multiorgan dysfunction (MESH:D009102), PDR (MESH:C564461), Acinetobacter baumannii infections (MESH:D000151), infection (MESH:D007239), pneumonia (MESH:D011014), renal injury (MESH:D007674), toxicity (MESH:D064420)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13041347/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC13041347/full.md

---
Source: https://tomesphere.com/paper/PMC13041347